Skip to main content

Table 1 Baseline characteristics, anthropometric, and laboratory data of the studied patients

From: Lipid profile of childhood cancer survivors and the effects of vitamin D supplementation: a prospective study

  All studied patients (57 patients) Obese patients (17 patients) Non-obese patients (40 patients) P value
Age on study (years)
 Median (IQR) 14.9 (11.15, 17.0) 16.6 (15.4, 17.0) 12.8 (9.8, 16.8) 0.001*
 [Minimum-maximum] [5.1-18] [11.7-18] [5.1-18]
Sex
 Male:female 24 (40.4%):33 (59.6) 5 (23.5%):12 (76.5%) 19 (47.5%):21 (52.5%) 0.15
Type of malignancy
 Leukemia/lymphoma 41 (71.9%) 12 (70.6%) 29 (72.5%) 0.88
 Solid tumor 16 (28.1%) 5 (29.4%) 11 (27.5%)
Weight (kg) 44.97 ± 19.1 68.9 ± 12.9 33.8 ± 10.8 < 0.001*
BMI (kg/m2) 21.11 ± 5.97 29.4 ± 3.27 17.0 ± 1.96 < 0.001*
Initial VD status
 VDD (25OH-VD < 20 ng/ml) 35 (61.4%) 15 (88.2%) 20 (50%) 0.020*
 VDI (25OH-VD, 20-30 ng/ml) 15 (26.3%) 1 (5.9%) 14 (35%)  
 VDS (25OH-VD ≥ 30 ng/ml) 7 (12.3%) 1 (5.9%) 6 (15%)  
Calcium (mg/dl) 9.8 ± 0.7 9.9 ± 0.5 9.7 ± 0.6 0.27
Phosphorus (mg/dl) 5.2 ± 1.5 5.2 ± 1.3 5.3 ± 1.8 0.33
Magnesium (mg/dl) 2.43 + 0.32 2.31 ± 0.25 2.45 ± 0.30 0.09
PTH (pgm/ml) 44.5 ± 9.0 44.7 ± 10.7 45.4 ± 9.2 0.53
TC (mg/dl) 175.51 + 49.73 182.6 ± 22.3 171.4 ± 24.2 0.014*
TG (mg/dl) 85.35 + 31.89 88.7 ± 45.2 83.0 ± 24.3 0.64
HDL-C (mg/dl) 41.67 + 12.24 42.5 ± 12.6 41.5 ± 11.3 0.966
LDL-C (mg/dl) 104.86 + 20.39 109.8 ± 26.8 90.5 ± 25.3 0.039*
  1. BMI body mass index, PTH parathyroid hormone, 25OH-VD 25-hydroxyvitamin D, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol, SD standard deviation, IQR inter-quartile range, VDD vitamin D deficient, VDI vitamin D insufficient, VDS vitamin D sufficient
  2. *P ≤ 0.05 (comparison of obese versus non-obese patients)